QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 0.011
-- x --
-- x --
-- - --
$ 0.01 - $ 1.67
2,640,038
na
na
$ 2.41
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 softbank-backed-cohesity-to-acquire-veritas-data-security-unit-for-3b-report

Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary ...

 us-stocks-gain-uber-posts-upbeat-sales

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market openin...

 softbank-backed-genetic-testing-invitaes-descent-from-7b-valuation-to-near-bankruptcy

Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options ...

 invitae-hires-fti-kirkland--ellis-to-advise-options-to-address-15b-of-debt-as-company-prepares-for-bankruptcy-co-has-been-selling-assets-to-shore-up-liquidity-as-business-tanks---wsj

https://www.wsj.com/articles/softbank-backed-medical-genetics-company-invitae-prepares-for-bankruptcy-d468f120?st=02yzwzf1bnabm...

Core News & Articles

 Invitae (NYSE:NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (NASDAQ:BBI...

 us-court-prohibits-neogenomics-to-sell-type-of-diagnostic-kits-to-detect-smaller-number-of-cancer-cells-favoring-natera-in-lawsuit

Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina...

 invitae-has-divested-the-assets-of-ciitizen-and-announced-strategic-cost-cuts-which-will-include-a-workforce-reduction-and-other-operating-expense-reductions

oday, the company also implemented efforts to significantly reduce its operating expenses via a workforce reduction and other c...

 piper-sandler-maintains-underweight-on-invitae-lowers-price-target-to-03

Piper Sandler analyst David Westenberg maintains Invitae (NYSE:NVTA) with a Underweight and lowers the price target from $0....

 why-amc-entertainment-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

 invitae-reaffirms-fy23-revenue-480m-500m-vs-48602m-est

Reaffirming Fiscal 2023 OutlookFor the full year, Invitae is reaffirming its fiscal 2023 outlook. The Company expects revenue i...

 invitae-q3-eps-010-beats-031-estimate-sales-12124m-beat-12102m-estimate

Invitae (NYSE:NVTA) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.31) by 67.7...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 earnings-preview-invitae
Earnings Preview: Invitae
11/07/2023 16:02:01

 invitae-announces-study-published-in-jama-network-open-on-the-largest-study-to-date-on-uncertain-results-from-hereditary-disease-genetic-testing-the-study-evaluated-data-from-more-than-16m-individuals-undergoing-multi-gene-panel-testing

Invitae (NYSE:NVTA), a leading medical genetics company, today announced findings from the largest study to date on uncertain r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION